Thank you for attending today's DT & IT Pharma Townhall! In today's meeting, we delved deeper into the successful launch of the Pharma Control Tower (go/PHCT), which serves as a central entry point for all your needs related to financial, operational stability, and governance for your applications, portfolios, and functions. Additionally, we shared some updates on the rollout of MyGenAssist at Pharma, highlighting our crucial role as key ambassadors. This past year has underscored the accelerated pace of innovation, with GenAI standing out as a prime example of the agility needed to proactively evolve our skill sets. Furthermore, we collectively reviewed our key priorities for 2024 and provided updates on our DSO learning journey. In summary: ///// PH Control Tower ///// Business priorities per department ///// MyGenAssist roll-out PH ///// DSO Champions update Bayer terms & conditions apply: https://www.bayer.com/en/poap-tc

Another DSO Open MIC session is in the books! Thank you for attending today's afternoon session. These sessions are a space for open exchanges about ongoing topics around DSO and an opportunity to share, ask questions, provide feedback, or just listen. Everyone is invited to attend, participation is voluntary, and the sessions will not be recorded. Bayer terms & conditions apply: https://www.bayer.com/en/poap-tc

Dear Team, A huge thank you to everyone who joined our recent Global DT&IT Pharma Townhall. Your participation not only made it a success, it also added to the beauty of this time of the year when the snowflakes fall and the air transmits the smell of muled wine and fresh bakery. Reflecting on our team's achievements and exploring Dynamic Shared Ownership (DSO) was insightful, thanks to your active engagement. The shared pictures highlighted our milestones beautifully. Your contributions in discussions and ideas truly enriched the event. Your dedication and support are immensely valued. Let's continue fostering collaboration and empowerment in our work. Thanks again for being a part of this success! Best regards, Patrick Text's draft modified by Open AI's ChatGPT Art inspired by Open AI's Dall-E

En este evento académico, los médicos especialistas tendrán la oportunidad de conocer e intercambiar acerca de los tratamientos anticoagulantes en fibrilación auricular no valvular. Con foco en la innovación y en mejorar la calidad de vida de los pacientes, Bayer también se enorgullece de promover prácticas y tecnologías Web 3.0 innovadoras como NFT POAPs. Este es el primer POAP NFT en Bolivia y tercero en el mundo relacionado con un producto farmacéutico. Si recibió este POAP, usted es un verdadero pionero en el espacio Web 3.0. Por favor lea los términos y condiciones de Bayer POAPs en el siguiente enlace: https://bayer.com/poap Para más información sobre Bayer Web3 contacte a: jesusdelvalle@bayer.com o marianoel.sosa@bayer.com o maribel.rovetto@bayer.com.